Top Markets
Coin of the day
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Rangering i aksjer #34062
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Aksjekurs
$0.223
Sist synkronisert: 2026-08-14
Markedsverdi
$6.32M
Endring (1 dag)
1.64%
Endring (1 år)
-
Land
US
Handel Curanex Pharmaceuticals Inc Common Stock (CURX)

Kategori

Antall utestående aksjer for Curanex Pharmaceuticals Inc Common Stock (CURX)
Antall utestående aksjer per August 2026: 0
Ifølge Curanex Pharmaceuticals Inc Common Stock sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Curanex Pharmaceuticals Inc Common Stock (CURX) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE